Please check your internet connection and try again.
# Lorazepam
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, anticonvulsant, and muscle relaxant properties. It acts by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor, resulting in a decrease in neuronal excitability.
## Primary Indications
* **Anxiety Disorders:** Short-term management of anxiety symptoms.
* **Insomnia:** Short-term treatment of insomnia characterized by difficulty falling or staying asleep.
* **Status Epilepticus:** Treatment of choice for prolonged or recurrent seizures.
* **Preoperative Sedation:** To reduce anxiety and provide amnesia prior to surgical procedures.
* **Symptomatic relief of alcohol withdrawal.**
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally two to three times daily. Maximum dose typically not to exceed 10 mg daily, but may be higher in specific clinical scenarios under close supervision.
* **Insomnia:** 2 mg to 4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg intravenously or intramuscularly. A second dose of 4 mg may be administered 5 to 10 minutes after the first dose if seizures persist.
* **Preoperative Sedation:** 1 mg to 4 mg orally or intramuscularly 1 to 2 hours before surgery.
* **Alcohol Withdrawal:** Initial dose: 1 mg to 4 mg orally or intramuscularly. Subsequent doses: 1 mg to 2 mg every 4 to 6 hours as needed. Dosing is highly individualized and dependent on symptom severity.
## Pediatric Dosing
Dosing in pediatric patients is less well-established and should be guided by expert consensus or institutional protocols.
* **Status Epilepticus:** Intravenous: 0.1 mg/kg, maximum dose of 4 mg per dose.
* **Sedation/Anxiety:** Dosing varies widely. Oral doses are typically much lower than adult doses. For example, some sources suggest 0.025 to 0.1 mg/kg/dose every 6 to 8 hours.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment is typically recommended for mild to moderate impairment, but caution is advised.
* **Elderly:** Start with lower doses (e.g., half of the adult dose) due to increased sensitivity and potential for prolonged half-life.
## Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Sleep apnea.
## Adverse Effects
* **Common:** Sedation, dizziness, fatigue, unsteadiness, weakness.
* **Less Common:** Confusion, depression, anterograde amnesia, paradoxical excitation, ataxia, slurred speech, blurred vision, hypotension.
* **Serious:** Respiratory depression, paradoxical reactions (e.g., aggression, rage), dependence, withdrawal symptoms upon abrupt discontinuation.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, sedatives, antipsychotics, antihistamines):** Additive CNS depression, increasing the risk of profound sedation, respiratory depression, coma, and death. Use together with extreme caution and consider dose reduction of one or both agents.
* **CYP450 Inhibitors/Inducers:** Lorazepam is primarily metabolized by glucuronidation, a pathway less affected by CYP450 enzymes. However, some drug interactions may still occur.
* **Theophylline/Aminophylline:** May decrease the sedative effects of lorazepam.
## Monitoring
* **Clinical response:** Assess for reduction in anxiety symptoms, improvement in sleep, or cessation of seizures.
* **Sedation level:** Monitor for excessive drowsiness, respiratory rate, and oxygen saturation, especially with parenteral administration or in combination with other CNS depressants.
* **Signs of dependence/withdrawal:** Monitor for withdrawal symptoms if the patient is on long-term therapy and dose is being reduced or discontinued.
* **Abuse potential:** Assess for risk factors and signs of misuse.
## Clinical Pearls
* Lorazepam has a relatively long half-life, which can contribute to prolonged sedation.
* Intramuscular absorption can be erratic. Intravenous administration is preferred for status epilepticus for faster onset.
* Tolerance to the sedative and hypnotic effects can develop with prolonged use.
* Abrupt discontinuation after prolonged use can lead to withdrawal symptoms, including anxiety, insomnia, tremors, muscle cramps, and, in severe cases, seizures. Tapering of the dose is recommended.
* Consider risks and benefits in patients with a history of substance abuse.
***
**Disclaimer:** This information is intended for clinical use and does not replace a thorough review of the current prescribing information and relevant literature. Always verify current dosing, indications, contraindications, and safety warnings with official drug information resources and institutional protocols.
